![Patrick F. Terry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick F. Terry
Direktor/Vorstandsmitglied bei MeMed Diagnostics Ltd.
Ursprung des Netzwerks ersten Grades von Patrick F. Terry
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel.
15
| Holding Company | Medical Specialties | 15 |
Inivata Ltd.
![]() Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom.
8
| Holding Company | Packaged Software | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Patrick F. Terry
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Corporate Officer/Principal | |
MOBILEYE BV | Computer Communications | Director/Board Member | |
Dxterity Diagnostics, Inc.
![]() Dxterity Diagnostics, Inc. Medical/Nursing ServicesHealth Services Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA. | Medical/Nursing Services | Director/Board Member | |
Personal Genome Diagnostics, Inc.
![]() Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD. | Biotechnology | Chief Operating Officer | |
University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
McGill University | College/University | Undergraduate Degree | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
Oregon State University | College/University | Doctorate Degree | |
University of Toronto | College/University | Undergraduate Degree Doctorate Degree | |
University of Western Ontario | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Doctorate Degree | |
Technion-Israel Institute of Technology | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
IP2IPO Innovations Ltd.
![]() IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Banyan Biomarkers, Inc.
![]() Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
Touchstone Innovations Investment Management Ltd.
![]() Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member Private Equity Analyst | |
T2 BIOSYSTEMS, INC. | Medical Specialties | Private Equity Investor | |
Stanmore Implants Worldwide Ltd.
![]() Stanmore Implants Worldwide Ltd. Medical SpecialtiesHealth Technology Stanmore Implants Worldwide, Ltd. designs and manufactures bespoke and modular implants for limb sparing and complex joint replacement. It provides massive endoprothesis tumour systems for orthopedic skeletal locations including the femur, tibia, knee, pelvis and humerus. The firm also offers computer assisted orthopedic surgeries. The company was founded on February 19, 1996 and is headquartered in Elstree, the United Kingdom. | Medical Specialties | Director/Board Member | |
Compagnie Merieux Alliance SAS
![]() Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Private Equity Investor | |
SCINAI IMMUNOTHERAPEUTICS LTD. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Pictor Ltd.
![]() Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Biotechnology | Chief Executive Officer | |
Tornado Spectral Systems, Inc.
![]() Tornado Spectral Systems, Inc. Medical SpecialtiesHealth Technology Tornado Spectral Systems, Inc. develops real-time optical process analyzers and imaging solutions. Its optical solutions include HyperFlux PRO Plus, HyperFlux PRO and HyperFlux U1. The firm offers its services to pharmaceuticals, oil and gas, bio processing, specialty chemical, plastics and polymers industries. The company was founded by Jae Kim and Arsen R. Hajian in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Private Equity Investor | |
Nascient Ltd.
![]() Nascient Ltd. BiotechnologyHealth Technology Nascient Ltd. develops a novel antibody treatment for rheumatoid arthritis. The company was founded by Phil Bland-Ward, Kim Midwood and Nigel Robert Burns in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Company Builders LLC
![]() Company Builders LLC Miscellaneous Commercial ServicesCommercial Services Company Builders LLC provides business development consulting services. The private company is based in Albuquerque, NM. The CEO of the company is Paul Andrew Ruppanner. | Miscellaneous Commercial Services | Chairman | |
Columbia Business School | College/University | Masters Business Admin | |
Synthace Ltd.
![]() Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Packaged Software | Director/Board Member | |
Accellta Ltd.
![]() Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Biotechnology | Director/Board Member | |
IAT Automotive, Inc. | President | ||
IAT Holdings LLC | Corporate Officer/Principal | ||
Durawool, Inc. | President | ||
Zhuhai Dazheng Metal Fiber Co., Ltd. | Chairman | ||
Qvella Corp.
![]() Qvella Corp. Medical SpecialtiesHealth Technology Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada. | Medical Specialties | Director/Board Member | |
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
Oxular Ltd.
![]() Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Obsidian Therapeutics, Inc.
![]() Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
ApcinteX Ltd.
![]() ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
BiomX Ltd.
![]() BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Demetrix, Inc.
![]() Demetrix, Inc. Pharmaceuticals: OtherHealth Technology Demetrix, Inc. manufactures natural medicines. The company was founded by William Haseltine and Jay Keasling in 2015 and is headquartered in Emeryville, CA. | Pharmaceuticals: Other | Director/Board Member | |
Federation Bio, Inc.
![]() Federation Bio, Inc. BiotechnologyHealth Technology Federation Bio, Inc. uses microbiome therapeutics to address medical needs. The company was founded by Racquel N. Bracken, Michael Fischbach and Dylan Dodd and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
BIOMX INC. | Biotechnology | Director/Board Member | |
Omx Ventures LLC
![]() Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | Investment Managers | Private Equity Investor | |
Canopy Immuno - Therapeutics Ltd.
![]() Canopy Immuno - Therapeutics Ltd. BiotechnologyHealth Technology Canopy Immuno-Therapeutics Ltd. is based in Megadim, Israel. Canopy Immuno-Therapeutics operates as an Israeli pre-clinical stage biotech company. Canopy Immuno - Therapeutics Ltd. was founded by Kfir Oved and he has been the CEO since incorporation. | Biotechnology | Chief Executive Officer | |
Mobility Health, Inc. | Director/Board Member | ||
Veryan Medical Ltd.
![]() Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
The Royal Veterinary College | College/University | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 18 |
Vereinigtes Königreich | 14 |
Israel | 9 |
Kanada | 8 |
Frankreich | 2 |
Sektoral
Health Technology | 20 |
Consumer Services | 12 |
Finance | 5 |
Health Services | 4 |
Commercial Services | 4 |
Operativ
Director/Board Member | 63 |
Corporate Officer/Principal | 27 |
Chief Executive Officer | 19 |
Chairman | 14 |
President | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Patrick F. Terry
- Unternehmensverbindungen